Advertisement

Related Videos

Welcome and Introduction to Vi3C

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

David A. Hyman, MD, JD, on Inclusive Shared Savings

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Advertisement

Advertisement




Feb
19
Today In Oncology
Genetics Pioneer Zsofia Stadler to Lead JCO Precision Oncology
Does Diabetes Increase Pancreatic Cystic Neoplasm Risk
Topline PFS Results From BREAKWATER in mCRC Newly Announced
Adding Encorafenib and Cetuximab to FOLFIRI Shows Benefit in BRAF-Mutant Colorectal Cancer
Pleurectomy Decortication Safe in Select Patients With Pleural Mesothelioma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo